PREcision MEDicine In Achalasia (PREMEDIA)

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Northwestern University
Study ID
NCT07293650
Phase
PHASE3
Status
Recruiting

Conditions

  • EGJ Outflow Obstruction Without Spastic/Hypercontractile Features
  • Type I Achalasia
  • Type II Achalasia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Standard Myotomy — PROCEDURE
    Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.
  • Tailored Short Myotomy — PROCEDURE
    Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.

Study Details

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]: * Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms? * Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut. Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Key Dates

First listed
Dec 19, 2025
Start date
Apr 29, 2026
Status verified
Aug 2026
Primary completion
Aug 31, 2031
Completion
Aug 1, 2032

Study Design

Enrollment
372 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Standard Myotomy
  • Experimental: Tailored Short Myotomy

Primary Outcome Measure

Clinical Response-Overall [ Time Frame: From enrollment to Year 2 ]

Central Contacts

Locations (16)

FacilityCityStateZIPSite coordinators
Mayo Clinic ArizonaScottsdaleArizona85259-
University of California San DiegoLa JollaCalifornia92093-
University of Colorado DenverDenverColorado80217-
University of FloridaGainesvilleFlorida32611
April Goddard, Lead Study Coordinator, PA-C
352-273-9483
Peter Draganov, MD (PRINCIPAL_INVESTIGATOR)
Adventist Health System/Sunbelt, IncOrlandoFlorida32803-
Emory UniversityAtlantaGeorgia30322
Halley Fowler, Lead Study Coordinator
404-778-3184
Anand Jain, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Eric Pfannkuche, Lead Study Coordinator
312-926-4525
John Pandolfino, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins UniversityBaltimoreMaryland21218-
Massachusetts General HospitalBostonMassachusetts02114
Madison Paylor, Lead Study Coordinator
617-726-0196
Kyle Staller, MD (PRINCIPAL_INVESTIGATOR)
Washington UniversitySt LouisMissouri63130-
Weill Cornell Medical CollegeNew YorkNew York10065-
Atrium Health/Wake ForestCharlotteNorth Carolina28204
Greg Scarola, Lead Study Coordinator
(704) 355-2000
Badih Elmunzer, MD (PRINCIPAL_INVESTIGATOR)
Case Western Reserve UniversityClevelandOhio44106-
MetroHealth Medical CenterClevelandOhio44109
Stephanie Baker, Lead Study Coordinator
216-778-5736
Ronnie Fass, MD (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical CenterNashvilleTennessee37232
Larry Raber, Lead Study Coordinator
615-322-4643
Dhyanesh Patel, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White HealthDallasTexas75204-

Find similar trials in Scottsdale, AZ